|
V.TLT
|
I do believe that there is an extremely good chance of that happening and...
|
|
V.TLT
|
They may expect SP to head quite a bit higher soon enough to have those...
|
|
V.TLT
|
A 5% dilution took us down temporarily almost 30% from 0.35. StevenBirch...
|
|
V.TLT
|
Good. At least company has about $3.6 Million in cash now until at least a...
|
|
V.TLT
|
A small correction as from 1st set of 12 only 6 were NR, not 9, as 3 were CR...
|
|
V.TLT
|
To complete my point, at 90 days if we end up excluding at least 10...
|
|
V.TLT
|
Nice observations. If we only look at the NR patients at 90 days, the...
|
|
V.TLT
|
Excellent summary and comparison. When we look at these numbers, we...
|
|
V.TLT
|
I have no clue why Dr Vera has left, but the first idea, would be that she...
|
|
V.TLT
|
Just want to add that when final numbers come in, even at 360 days on this...
|
|
V.TLT
|
Excellent improvement as we see more of the optimized patients bring up the...
|
|
V.TLT
|
With 2nd treatment if we can maintain a similar 360 and 450 day efficacy as...
|
|
V.TLT
|
Still here. Been busy on vacation.
|
|
V.TLT
|
steamfitter wrote: My question is within the statement above in regards to...
|
|
V.TLT
|
From April 5th PH2 trial update till now, 4 extra patients have reached 270...
|
|
V.TLT
|
The last official trial update was April 5th, then we got a bit more...
|
|
V.TLT
|
Thanks for the update. Very good to hear.
|
|
V.TLT
|
Did they mention possible catalysts as JV or BO, as well as BTD? ...
|
|
V.TLT
|
And https://criterionedge.com/what-are-the-major-regulatory-differences...
|
|
V.TLT
|
https://criterionedge.com/manufacturing-and-immunogenicity-are-key...
|